Gilead set to open $250m, 23-acre campus

05:50 EDT 15 Aug 2017 | Pharmafile

Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of work. The facility, once it is running at full capacity, is it to create jobs for 500 workers.

The campus will initially focus on the manufacture of AmBisome, an antifungal medication that is used to combat fungal infections and a form of meningitis in people carrying HIV. As well as this, the campus will have the capacity to package, label and distribute other treatments owned by the company, including its hepatitis C treatments.

read more

Original Article: Gilead set to open $250m, 23-acre campus


More From BioPortfolio on "Gilead set to open $250m, 23-acre campus"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...